The GCC biocatalyst market size reached 1,010 Tons in 2024. Looking forward, IMARC Group expects the market to reach 1,470 Tons by 2033, exhibiting a growth rate (CAGR) of 4.06% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | 1,010 Tons |
Market Forecast in 2033 | 1,470 Tons |
Market Growth Rate (2025-2033) | 4.06% |
Biocatalysts refer to enzymes or microbes that accelerate or initiate chemical reactions in a living body. They are generally present in living organisms, including plants, animals and microorganisms, that helps in modifying the rate of chemical reactions and conversion of organic compounds. Apart from this, they are utilized for industrial purposes due to their ability to withstand mild conditions. Additionally, they are also used in the pharmaceutical industry to manufacture statins, antibodies, amino acids and vitamins.
The market in the GCC region is primarily driven by significant growth in the field of biotechnology. Along with this, multiple key players in the region are actively engaging in joint ventures to strengthen their market presence. Moreover, continual technological advancements across the GCC region, such as the deployment of machine learning (ML) and biosensors with biocatalysis processes, are also positively influencing the market growth. Some of the other factors contributing to the market growth include the increasing investments by the governments of numerous countries across the GCC region to conduct extensive research and development (R&D) activities and the rapid substitution of chemical catalysts with biocatalysts across industries.
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC biocatalyst market report, along with forecasts at the regional and country level from 2025-2033. Our report has categorized the market based on type, application and source.
Breakup by Type:
Breakup by Application:
Breakup by Source:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Kilo Tons |
Segment Coverage | Type, Application, Source, Country |
Countries Covered | Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The GCC biocatalyst market reached a volume of 1,010 Tons in 2024.
We expect the GCC biocatalyst market to exhibit a CAGR of 4.06% during 2025-2033.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several GCC nations resulting in the temporary closure of numerous end-use industries for biocatalysts.
The rising demand for biocatalyst in the production of biofuels and biopharmaceuticals, owing to its environment sustainability, is primarily driving the GCC biocatalyst market.
Based on the type, the GCC biocatalyst market can be categorized into hydrolases, oxidoreductases, transferases, and others. Currently, hydrolases account for the majority of the total market share.
Based on the application, the GCC biocatalyst market has been segregated into food and beverages, cleaning agent, biofuel production, agriculture and feed, biopharmaceuticals, and others. Among these, food and beverages currently hold the largest market share.
Based on the source, the GCC biocatalyst market can be bifurcated into microorganisms, plants, and animals. Currently, microorganisms exhibit a clear dominance in the market.
On a regional level, the market has been classified into Saudi Arabia, UAE, Qatar, Oman, Kuwait, and Bahrain, where Saudi Arabia currently dominates the GCC biocatalyst market.